Hong Bo Young, Jo Leechan, Kim Joon Sung, Lim Seong Hoon, Bae Jung Min
Department of Rehabilitation Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.
Department of Dermatology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.
J Korean Med Sci. 2017 May;32(5):873-879. doi: 10.3346/jkms.2017.32.5.873.
The study was designed to identify factors influencing the short term effect of intensive therapy on gross motor function in children with cerebral palsy or developmental delay. Retrospectively, total Gross Motor Function Measure-88 (GMFM-88) scores measured during the first and last weeks of intensive therapy were analyzed (n = 103). Good and poor responder groups were defined as those in the top and bottom 25% in terms of score difference, respectively. The GMFM-88 score increased to 4.67 ± 3.93 after 8 weeks of intensive therapy (P < 0.001). Gross Motor Function Classification System (GMFCS) level (I-II vs. IV-V; odds ratio [OR] = 7.763, 95% confidence interval [CI] = 2.177-27.682, P = 0.002) was a significant factor in a good response to therapy. Age (≥ 36 months; OR = 2.737, 95% CI = 1.003-7.471, P = 0.049) and GMFCS level (I-II vs. IV-V; OR = 0.189, 95% CI = 0.057-0.630, P = 0.007; and III vs. IV-V; OR = 0.095, 95% CI = 0.011-0.785, P = 0.029) were significantly associated with a poor response. GMFCS level is the most important prognostic factor for the effect of intensive therapy on gross motor function. In addition, age ≥ 36 months, is associated with a poor outcome.
该研究旨在确定影响强化治疗对脑瘫或发育迟缓儿童粗大运动功能短期效果的因素。回顾性分析了强化治疗第一周和最后一周测量的总粗大运动功能测量-88(GMFM-88)分数(n = 103)。根据分数差异,分别将反应良好组和反应较差组定义为得分最高和最低的25%。强化治疗8周后,GMFM-88分数增加到4.67±3.93(P < 0.001)。粗大运动功能分类系统(GMFCS)水平(I-II级与IV-V级;优势比[OR] = 7.763,95%置信区间[CI] = 2.177-27.682,P = 0.002)是治疗反应良好的一个重要因素。年龄(≥36个月;OR = 2.737,95% CI = 1.003-7.471,P = 0.049)和GMFCS水平(I-II级与IV-V级;OR = 0.189,95% CI = 0.057-0.630,P = 0.007;III级与IV-V级;OR = 0.095,95% CI = 0.011-